Fructose during pregnancy affects maternal and fetal leptin signaling

Journal of Nutritional Biochemistry

Volumn 24, Issue 10, 2013, Pages 1709-1716

  Rodríguez, Lourdes ^a   Panadero, María I ^a   Roglans, Núria ^b   Otero, Paola ^a   Álvarez Millán, Juan J ^c   Laguna, Juan C ^b   Bocos, Carlos ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CQS Lab   (Spain)

Author keywords

Fructose; Leptin; Pregnancy; Rat; Triglycerides

Indexed keywords

FRUCTOSE; LEPTIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; FATTY LIVER; FEMALE; FETUS; GLUCOSE INTAKE; GLUCOSE METABOLISM; HORMONE ACTION; HYPERLEPTINEMIA; HYPERTRIGLYCERIDEMIA; LIPID LIVER LEVEL; LIPID METABOLISM; MATERNAL NUTRITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANCY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SUGAR INTAKE;

ANIMALIA; RATTUS;

FRUCTOSE; LEPTIN; PREGNANCY; RAT; TRIGLYCERIDES;

ANIMALS; BLOOD GLUCOSE; FASTING; FEMALE; FETUS; FOOD; FRUCTOSE; GLUCOSE; HYPERTRIGLYCERIDEMIA; LEPTIN; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRIGLYCERIDES;

EID: 84883802726     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.02.011     Document Type: Article

References (49)

1. Howie G.J., Sloboda D.M., Kamal T., Vickers M.H. Maternal nutritional history predicts obesity in adult offspring independent of postnatal diet. J Physiol 2009, 587(Pt 4):905-915.
2. Koletzko B., Broekaert I., Demmelmair H., Franke J., Hannibal I., Oberle D., et al. EU Childhood Obesity Project. Protein intake in the first year of life: a risk factor for later obesity? The E.U. childhood obesity project. Adv Exp Med Biol 2005, 569:69-79.
3. Koletzko B., von Kries R., Monasterolo R.C., Subías J.E., Scaglioni S., Giovannini M., et al. European Childhood Obesity Trial Study Group. Infant feeding and later obesity risk. Adv Exp Med Biol 2009, 646:15-29.
4. Rees W.D., McNeil C.J., Maloney C.A. The roles of PPARs in the fetal origins of metabolic health and disease. PPAR Res 2008, 2008:459030.
5. Havel P.J. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005, 63:133-157.
6. Tappy L., Lê K.A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010, 90:23-46.
7. Johnson R.J., Segal M.S., Sautin Y., Nakagawa T., Feig D.I., Kang D.H., et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007, 86:899-906.
8. Johnson R.J., Pérez-Pozo S.E., Sautin Y., Manitius J., Sánchez-Lozada L.G., Feig D.I., et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?. Endocr Rev 2009, 30:96-116.
9. Taghibiglou C.H., Carpentier A., Van Iderstine S.C., Chen B., Rudy D., Aiton A., et al. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. J Biol Chem 2000, 275:8416-8425.
10. Park J., Lemieux S., Lewis G.F., Kuksis A., Steiner G. Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats. J Lipid Res 1997, 38:2529-2536.
11. Roglans N., Sanguino E., Peris C., Alegret M., Vázquez M., Adzet T., et al. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats. J Pharmacol Exp Ther 2002, 302(1):232-239.
12. Roglans N., Vilà L., Farré M., Alegret M., Sánchez R.M., Vázquez-Carrera M., et al. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 2007, 45(3):778-788.
13. Stanhope K.L., Schwarz J.M., Keim N.L., Griffen S.C., Bremer A.A., Graham J.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009, 119:1322-1334.
14. Stanhope K.L., Bremer A.A., Medici V., Nakajima K., Ito Y., Nakano T., et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab 2011, 96:E1596-E1605.
15. Malik V.S., Popkin B.M., Bray G.A., Després J.P., Willett W.C., Hu F.B. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010, 33:2477-2483.
16. de Koning L., Malik V.S., Kellogg M.D., Rimm E.B., Willett W.C., Hu F.B. Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation 2012, 125(14):1735-1741.
17. Lê K.A., Ith M., Kreis R., Faeh D., Bortolotti M., Tran C., et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009, 89:1760-1765.
18. Lê K.A., Faeh D., Stettler R., Ith M., Kreis R., Vermathen P., et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr 2006, 84:1374-1379.
19. Panadero M.I., Herrera E., Bocos C. Different sensitivity of PPAR[U+F061] expression to nutritional changes in liver of suckling and adult rats. Life Sci 2005, 76:1061-1072.
20. Sevillano J., López-Pérez I.C., Herrera E., Ramos M.P., Bocos C. Englitazone administration to late pregnant rats produces delayed body growth and insulin resistance on their fetuses and neonates. Biochem J 2005, 389(3):913-918.
21. Soria A., Chicco A., Mocchiutti N., Gutman R.A., Lombardo Y.B., Martín-Hidalgo A., et al. A sucrose-rich diet affects triglyceride metabolism differently in pregnant and nonpregnant rats and has negative effects on fetal growth. J Nutr 1996, 126(10):2481-2486.
22. López-Soldado I., Munilla A., Herrera E. A sucrose-rich diet during pregnancy causes a similar response in Sprague-Dawley and Wistar rats. Ann Nutr Metab 2001, 45(6):285-290.
23. Soria A., Bocos C., Herrera E. Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats. J Lipid Res 2002, 43:74-81.
24. Soria A., Gonzalez M.C., Vidal H., Herrera E., Bocos C. Triglyceridemia and peroxisome proliferator-activated receptor-[U+F061] expression are not connected in fenofibrate-treated pregnant rats. Mol Cell Biochem 2005, 273:97-107.
25. Villarroya F., Bocos C., Giralt M., Ramos M.P., Herrera E., Sevillano J., et al. Pharmacological and gene modification-based models for studying the impact of perinatal metabolic disturbances in adult life. Adv Exp Med Biol 2009, 646:141-148.
26. Santana-Farré R., Mirecki-Garrido M., Bocos C., Henríquez-Hernández L.A., Kahlon N., Herrera E., et al. Influence of neonatal hypothyroidism on hepatic gene expression and lipid metabolism in adulthood. PLoS One 2012, 7(5):e37386.
27. Lustig R.H., Schmidt L.A., Brindis C.D. Public health: the toxic truth about sugar. Nature 2012, 482(7383):27-29.
28. Newnham J.P., Moss T.J., Nitsos I., Sloboda D.M., Challis J.R. Nutrition and the early origins of adult disease. Asia Pac J Clin Nutr 2002, 11(Suppl 3):S537-S542.
29. Sevillano J., de Castro J., Bocos C., Herrera E., Ramos M.P. Role of IRS-1 serine 307 phosphorylation and adiponectin in adipose tissue insulin resistance in late pregnancy. Endocrinology 2007, 148(12):5933-5942.
30. Muniyappa R., Lee S., Chen H., Quon M.J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-E26.
31. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
32. Bligh E.G., Dyer W.J. A rapid method for total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
33. Munilla M.A., Herrera E. Maternal hypertriglyceridemia during late pregnancy does not affect the increase in circulating triglycerides caused by the long-term consumption of a sucrose-rich diet by rats. J Nutr 2000, 130:2883-2888.
34. Franko K.L., Forhead A.J., Fowden A.L. Effects of maternal dietary manipulation during different periods of pregnancy on hepatic glucogenic capacity in fetal and pregnant rats near term. Nutr Metab Cardiovasc Dis 2009, 19(8):555-562.
35. Clapp J.F. Maternal carbohydrate intake and pregnancy outcome. Proc Nutr Soc 2002, 61(1):45-50.
36. Beck B., Richy S., Archer Z.A., Mercer J.G. Ingestion of carbohydrate-rich supplements during gestation programs insulin and leptin resistance but not body weight gain in adult rat offspring. Front Physiol 2012, 3:224. 10.3389/fphys.2012.00224.
37. Fergusson M.A., Koski K.G. Comparison of effects of dietary glucose versus fructose during preganacy on fetal growth and development in rats. J Nutr 1990, 120:1312-1319.
38. Vilà L., Roglans N., Perna V., Sánchez R.M., Vázquez-Carrera M., Alegret M., et al. Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. J Nutr Biochem 2011, 22(8):741-751.
39. Castro M.C., Massa M.L., Del Zotto H., Gagliardino J.J., Francini F. Rat liver uncoupling protein 2: changes induced by a fructose-rich diet. Life Sci 2011, 89(17-18):609-614.
40. Dentin R., Girard J., Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 2005, 87(1):81-86.
41. Nagai Y., Nishio Y., Nakamura T., Maegawa H., Kikkawa R., Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPAR[U+F061]. Am J Physiol Endocrinol Metab 2002, 282:E1180-E1190.
42. Levy J.R., Lesko J., Krieg R.J., Adler R.A., Stevens W. Leptin responses to glucose infusions in obesity-prone rats. Am J Physiol Endocrinol Metab 2000, 279(5):E1088-E1096.
43. Herrera E., Lasunción M.A., Asunción M. Placental transport of free fatty acids, glycerol and ketone bodies. Fetal and Neonatal Physiology 1992, 291-298. WB Saunders, Philadelphia, PA, USA. R. Polin, W.W. Fox (Eds.).
44. Miyazaki M., Kim Y.-C., Gray-Keller M.P., Attie A.D., Ntambi J.M. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem 2000, 275(39):30132-30138.
45. Zhou Y.-T., Wang Z.-W., Higa M., Newgard C.B., Unger R.H. Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA 1999, 96:2391-2395.
46. Unger R.H., Zhou Y.-T., Orci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci USA 1999, 96:2327-2332.
47. Münzberg H., Björnholm M., Bates S.H., Myers M.G. Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 2005, 62:642-652.
48. Vilà L., Roglans N., Alegret M., Sánchez R.M., Vázquez-Carrera M., Laguna J.C. Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology 2008, 48(5):1506-1516.
49. Forhead A.J., Fowden A.L. The hungry fetus? Role of leptin as a nutritional signal before birth. J Physiol 2009, 587(6):1145-1152.